Hjem
Rune Johan Ulviks bilde

Rune Johan Ulvik

Professor
  • E-postRune.Ulvik@uib.no
  • Telefon+47 55 97 31 49+47 55 97 31 00
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • 2016. The prevalence of anemia and iron deficiency is more common in breastfed infants than their mothers in Bhaktapur, Nepal. European Journal of Clinical Nutrition. 456-462.
  • 2015. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics. 3361-3369.
  • 2015. Bloodletting therapy in hemochromatosis: Does it affect trace element homeostasis? Journal of Trace Elements in Medicine and Biology. 225-229.
  • 2014. Iron deficiency is uncommon among lactating women in urban Nepal, despite a high risk of inadequate dietary iron intake. British Journal of Nutrition. 132-141.
  • 2014. Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis. Blood Transfusion. s84-s89.
  • 2013. Quantitative proteomics comparison of arachnoid cyst fluid and cerebrospinal fluid collected perioperatively from arachnoid cyst patients. Fluids and Barriers of the CNS.
  • 2013. Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. Journal of Proteomics. 312-325.
  • 2011. Protein profiling reveals inter-individual protein homogeneity of arachnoid cyst fluid and high qualitative similarity to cerebrospinal fluid. Fluids and Barriers of the CNS.
  • 2011. Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis -- a pilot study. Scandinavian Journal of Clinical and Laboratory Investigation. 269-273.
  • 2010. Natural Killer Cells as Biomarkers of Hyperbaric Stress During a Dry Heliox Saturation Dive. Aviation, Space and Environmental Medicine. 467-474.
  • 2010. Effekten av blodgivningsfrekvens på jernstatus. Bioingeniøren. 6-10.
  • 2010. Effect of iron supplementation on iron status during the first week after blood donation. Vox Sanguinis. e249-e256.
  • 2010. Blood donors with hereditary hemochromatosis. Transfusion. 1787-1793.
  • 2010. Arachnoid cysts do not contain cerebrospinal fluid: A comparative chemical analysis of arachnoid cyst fluid and cerebrospinal fluid in adults. Cerebrospinal Fluid Research.
  • 2009. The effect of blood donation frequency on iron status. Transfusion and Apheresis Science. 165-169.
  • 2009. The effect of blood donation frequency on iron status. Transfusion and Apheresis Science. 165-169.
  • 2009. Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. Diabetes, obesity and metabolism. 304-314.
  • 2009. Iron status in Norwegian blood donors: comparison of iron status in new blood donors registered in 1993-1997 and in 2005-2006. Vox Sanguinis. 49-55.
  • 2009. Iron status in Norwegian blood donors: comparison of iron status in new blood donors registered in 1993-1997 and in 2005-2006. Vox Sanguinis. 49-55.
  • 2009. Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. Diabetes, obesity and metabolism. 1034-1049.
  • 2009. Biomarker discovery in mass spectral profiles by means of selectivity ratio plot. Chemometrics and Intelligent Laboratory Systems. 35-48.
  • 2008. Pharmacology and safety of tetradecylthioacetic acid (TTA): phase-1 study. Journal of Cardiovascular Pharmacology. 410-417.
  • 2007. Prevalence of iron deficiency and anemia among healthy women of reproductive age in Bhaktapur, Nepal. European Journal of Clinical Nutrition. 262-269.
  • 2007. Pretreatment of mass spectral profiles: Application to proteomic data. Analytical Chemistry. 7014-7026.
  • 2007. Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. PROTEOMICS - Clinical Applications. 699-711.
  • 2006. Renal function of chloralkali workers after the cessation of exposure to mercury vapor. Scandinavian Journal of Work, Environment and Health. 241-249.
  • 2005. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 1058-1065.
  • 2005. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflammatory Bowel Diseases. 744-748.
  • 2005. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics. 831-838.
  • 2005. Changes in erythropoietin and haemoglobin concentrations in response to saturation diving. European Journal of Applied Physiology. 191-196.
  • 2004. Effects of tonsillectomy and adenoidectomy on hemoglobin and iron metabolism. International Journal of Pediatric Otorhinolaryngology. 419-423.
  • 2003. Iron status in manganese alloy production workers. Journal of Applied Toxicology. 239-247.
  • 2003. Intestinal and systemic immune responses to an oral B-subunit-whole-cell cholera vaccine administered during zinc supplementation. Infection and Immunity. 3909-3913.
  • 2003. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scandinavian Journal of Gastroenterology. 543-548.
  • 2002. Substantial Reduction in Severe Diarrheal Morbidity by Daily Zinc Supplementation in Young North Indian Children. Pediatrics. 86.
  • 2002. Multi-element analysis of trace element levels in human autopsy tissues using inductively coupled atomic emission spectrometry technique (ICP-AES). Journal of Trace Elements in Medicine and Biology. 15-25.
  • 2002. Effectiveness and efficacy of zinc for the treatment of acute diarrhea in young children. Pediatrics. 898-903.
  • 2002. Effect of routine zinc supplementation on pneumonia in children aged 6 months to 3 years: randomised controlled trial in an urban slum. BMJ. British Medical Journal. 1358-1362.
  • 2002. Anemia in pregnancy in rural Tanzania; associations with micro-nutritients status and infections. European Journal of Clinical Nutrition. 192-199.
  • 2001. Iron supplementation in pregnancy - evidence and controversies. Acta Obstetricia et Gynecologica Scandinavica. 683-688.
  • 2000. Validation of inductively coupled plasma atomic emission spectrometry technique (ICP-AES) for multi-element analysis of trace elements in human serum. Scandinavian Journal of Clinical and Laboratory Investigation. 677-686.
  • 2000. Trace element reference values in serum determined by inductively coupled plasma atomic emission spectrometry. Clinical Chemistry and Laboratory Medicine. 765-772.
  • 2000. Anemia in pregnancy: possible causes and risk factors in Nepali women. European Journal of Clinical Nutrition. 3-8.
  • 1997. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro. Arteriosclerosis, Thrombosis and Vascular Biology. 3255-3262.
  • 1997. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro. Arteriosclerosis, Thrombosis and Vascular Biology. 3255-3262.
  • 1997. Tetradecylthioacetic Acid Inibits the Oxidative Modification of Low Density Lipoprotein and 8-Hydroxydeoxyguanosine formation in Vitro. Arteriosclerosis, Thrombosis and Vascular Biology.
  • 1997. Salt restriction: effects on lipids and insulin production in hypertensive patients. Scandinavian Journal of Clinical and Laboratory Investigation. 501-506.
  • 1997. Salt restriction: effects on lipids and insulin production in hypertensive patients. Scandinavian Journal of Clinical and Laboratory Investigation. 501-506.
  • 1997. Nyere syn på profylaktisk jerntilskudd i normale svangerskap. Tidsskrift for Den norske legeforening. 966-969.
  • 1997. Nyere syn på profylaktisk jerntilskudd i normale svangerskap. Tidsskrift for Den norske legeforening. 966-969.
  • 1997. Jerntilskudd til gravide - retningslinjer på rett spor? Tidsskrift for Den norske legeforening. 2838.
  • 1997. Jerntilskudd til gravide - retningslinjer på rett spor. Tidsskrift for Den norske legeforening. 2838.
  • 1997. Iron supplementation in pregnancy: is less enough? A randomized, placebo controlled trial of low dose iron supplementation with and without heme iron. Acta Obstetricia et Gynecologica Scandinavica. 822-828.
  • 1997. Hvordan virker antioksidanter? Tidsskrift for Den norske legeforening. 1928-1932.
  • 1997. Hemoglobin, jernmangel og anemi hos gravide, Diagnostiske aspekter. Tidsskrift for Den norske legeforening. 962-966.
  • 1997. Hemoglobin, jernmangel og anemi hos gravide, Diagnostiske aspekter. Tidsskrift for Den norske legeforening. 962-966.
  • 1997. Effectiveness of two preventive interventions for coronary heart disease risk in primary care. Scandinavian Journal of Primary Health Care. 57-64.
  • 1996. Toksisk effekt av jern og andre medisinske konsekvenser. Cederroth Info.
  • 1996. Nordiske kurs i spesialistutdanningen i klinisk kjemi. Skjer det noe konkret? Nytt til medlemmene. 2.
  • 1996. Determination of manganese superoxide dismutase activity by direct spectrophotmetry. Free radical research. 541-546.
  • 1994. Salt restriction in hypertension - the effect of dietary advice and self monitoring of chloride concentration in urine. Scandinavian Journal of Clinical and Laboratory Investigation. 399-404.
  • 1994. Salt restriction in hypertension - The effect of dietary advice and self monitoring of chloride concentration in urine. Scandinavian Journal of Clinical and Laboratory Investigation. 399-404.
  • 1994. Salt restriction and increased insulin production in hypertensive patients. Scandinavian Journal of Clinical and Laboratory Investigation. 405-409.
  • 1994. Salt restriction and increased insulin production in hypertensive patients. Scandinavian Journal of Clinical and Laboratory Investigation. 405-409.
  • 1994. Salt restriction and increased insulin production in hypertensive patients. Scandinavian Journal of Clinical and Laboratory Investigation. 405-409.
  • 1994. Nytt utviklingsperspektiv for klinisk kjemi som medisinsk spesialitet. Tidsskrift for Den norske legeforening. 1552-1554.
  • 1994. Behov for fornyelse av spesialistutdanningen i klinisk kjemi? Klinisk Biokemi i Norden. 38-42.
  • 1993. Stimulated decay of superoxide caused by ferritin-bound copper. FEBS Letters. 262-267.
  • 1993. Normothermic liver ischemia in rats. Xanthine oxidase is not the main source of oxygen free radicals. Research in Experimental Medicine. 275-283.
  • 1993. Normothermic ischemia in rats. Xanthine oxidase is not the main source of oxygen free radicals. Research in Experimental Medicine. 275-283.
  • 1993. Effect of alluporinol on the concentration of endogenous glutathione in hepatocytes after an hour of normothermic liver ischemia. European Journal of Surgery. 355-359.
  • 1993. Decay of superoxide catalyzed by ferritin. FEBS Letters. 149-152.
  • 1993. Cholesterol screening: observed cholesterol reduction in a prospective study in Norway. European Journal of Public Health. 38-42.
  • 1993. Cholesterol screening: observed cholesterol reduction in a prospective study in Norway. European Journal of Public Health. 38-42.
  • 1993. Cholesterol screening and dietary changes: Results from a Norwegian campaign. Health values. 3-9.
  • 1993. Cholesterol screening and dietary change: results from a Norwegian campaign. Health values. 3-9.
  • 1993. Cholesterol screening and dietary change: Results from a Norwegian campaign. Health values. 3-9.
  • 1993. CHOLESTEROL SCREENING: Observed cholesterol reduction in a perspective study in Norway. European Journal of Public Health. 38-42.
  • 1993. Allupurinol does not affect the concentration of endogenous glutathione in liver cells in rats after 60 min of normothermic liver ischemia. European Journal of Surgery. 355-359.
  • 1992. The norwegian cholesterol campaign: a one year follow-up evaluation of a local action. Homeostasis. 239-245.
  • 1992. The Norwegian cholesterol campaign: A one year follow-up evaluation of a local action. Hemeostatis. 239-245.
  • 1992. Spesialistutdanning i klinisk kjemi i Norge. Klinisk Biokemi i Norden. 18-20.
  • 1992. Sixty minutes of normothermic ischemia in rat liver. The declining tissue concentration of hypoxanthine during reperfusion is not a wash-out phenomenon. European Surgical Research. 257-264.
  • 1992. Sixty minutes normothermic ischemia in rat liver: The declining tissue concentration of hypoxanthine during reperfusion is not a washout phenomenon. European Surgical Research. 257-264.
  • 1992. Rutinemessig bestemmelse av homocystein i plasma. Ny og forbedret mulighet for risikovurdering og diagnostikk ved utbredte sykdommer. Tidsskrift for Den norske legeforening. 2977-2980.
  • 1992. Rutinemessig bestemmelse av homocystein i plasma. Ny og forbedret mulighet for risikovurdering og diagnostikk av urbredte sykdommer. Tidsskrift for Den norske legeforening. 2977-2980.
  • 1992. Decay kinetics of 02.-studied by direct spectrophotQmetry. Interaction with catalytic and non-catalytic substances. Biochimica et Biophysica Acta. 1156 pp. 27-33.
  • 1991. Sixty-minute normothermic liver ischemia in rats. Evidence that allupurinol improves liver cell energy metabolism during reperfusion but timing of drug administration is important. Transplantation. 231-234.
  • 1991. Sixty-minute normothermic liver ischemia in rats. Evidence that Allopurinol improves liver cell energy metabolism during reperfusion but that timing and drug administration is important. Transplantation. 231-234.
  • 1991. Improvment of a direct spectrophotometric assay for routine determination of superoxide dismutase activity. Clinical Chemistry. 1993-1999.
  • 1990. Screening for hemochromatosis. Scandinavian Journal of Clinical and Laboratory Investigation. 90-93.
  • 1990. On the limited ability of superoxide to release iron from ferritin. European Journal of Biochemistry (EJB). 899-904.
  • 1990. 60 min normothermic liver ischemia in rats: Allupurinol in proves energy status and bile flow during reperfusion. European Surgical Research. 27-33.
Rapport
  • 1993. Hva skal jeg bli? En presentasjon av de ulike spesialitetene i medisin. (Red.: Bratebø, G. & Haug, C.). .
  • 1990. Valgterminen. .
Vitenskapelig foredrag
  • 2007. Target projection and proper data pre-treatment for the analysis of proteomic profiles.
  • 2007. Preteatment of Mass Spectral Profiles: Application to proteomic data.
  • 2007. Analysis of Proteomic Profiles.
  • 2003. Oral zinc supplementation modulates the immune response to an oral B-subunit-whole-cell cholera vaccine.
  • 2003. Effect of Ferrous Fumarate Supplementation in Dextran Sulfate Sodium Colitis in Rats.
  • 2002. Zinc administration in Nepalese children with acute diarrhea, who will benefit most?
  • 2001. Mucosal and systemic immune responses to the oral CTB-whole cell cholera vaccine (rBS-WC) administered during zinc supplementation to zinc-replete adults.
  • 2001. Mucosal and systemic immune responses to the oral CTB-whole cell cholera vaccine (rBS-WC) administered during zinc supplementation to zinc-replete adults.
  • 2001. Mucosal and systemic immune responses to the oral CTB-whole cell cholera vaccine (rBS-WC) administered during zinc supplementation to zinc-replete adults.
  • 1998. On the antioxidant effect of tetradecylthioacetic acid and tetradecylselenoacetic acid.
  • 1998. Antioxidant properties of 3-Thia fatty acids.
  • 1997. Jernintoleranse ved Crohn's sykdom.
  • 1997. Effectiveness of two preventive interventions for coronary heart disease risk in primary care.
  • 1996. Effectiveness of two preventive interventions for coronary heart disease risk in primary care.
  • 1994. Salt restriction may increase insulin production in hypertensive patients.
  • 1993. Kan saltreduksjon føre til økt insulinresistens hos hypertonikere?
Leder
  • 2001. Sterkere sentralisering av medisinsk laboratorievirksomhet ? Tidsskrift for Den norske legeforening. 1199.
  • 2001. Slutt på jern i brunosten. Tidsskrift for Den norske legeforening. 3502.
Leserinnlegg
  • 2003. Omorganisering av legeforeningen. Blir LVS nedlagt ? LVS-info. 35-35.
  • 2002. Ny strid om avdelingsledelse på sykehus. Paraplyen. Tidsskrift for Hordaland og Sogn og Fjordane legeforeninger. 22-23.
  • 2001. Osmolalitet og osmolaritet. Forskjeller og riktig bruk i medisinen. Tidsskrift for Den norske legeforening. 2080.
Short communication
  • 2015. En mann i 50-årene med høyt ferritinnivå og økende kognitiv svikt. Tidsskrift for Den norske legeforening. 1369-1372.
  • 2009. Transferrinmetning ikke screeningtest alene. Tidsskrift for Den norske legeforening. 2388.
Mastergradsoppgave
  • 2007. Proteomics applied on cerebrospinal fluid, with focus on methods development and candidate biomarker discovery in multiple sclerosis patients.
Populærvitenskapelig artikkel
  • 2003. Fra klinisk kjemi til medisinsk biokjemi. Om bakgrunnen for nytt navn på legespesialiteten. Bioingeniøren. 4-5.
  • 1993. Legers ansvar, norsk lov og "profesjonskamp". (Dobbelkronikk, 6.-7. mai 1993). Bergens Tidende.
Kronikk
  • 1993. Tillit eller ikke til Laboratorium for klinisk biokjemi ved Haukeland sykehus? Tidsskrift for Den norske legeforening. 367-367.
  • 1992. Årets lederseminar for helsetjenesten uten leger som forelesere (korrespondanse). Tidsskrift for Den norske legeforening. 3701-3701.
  • 1992. Utdanning av leger for det neste århundre.(Kronikk). Bergens Tidende.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • 1992. Stimulated disproportionation of superoxide by ferritin without concomitant release of Fe(II). Evidence for a catalytic role of ferritin. Oxygen Radicals.
  • 1990. Utredning av anemi. 11 sider.
  • 1990. Lever- og galleveissykdommer. 12 sider.
  • 1990. Jernstoffskiftet. 14 sider.
  • 1990. Glukosestoffskiftet og diabetes mellitus. 11 sider.
  • 1990. Evaluering. 10 sider.
Sammendrag/abstract
  • 2013. Bloodletting therapy in hemochromatosis: Does it effect trace elements homeostasis? American Journal of Hematology. E207-E207.
  • 2008. Early diagnosis and biomarker discovery from mass spectral profiles: application to multiple sclerosis. Multiple Sclerosis. S285-S285.
  • 2008. Biomarker discovery from mass spectral profiles: A combined proteomics and multivariate analysis. European Journal of Pharmaceutical Sciences. S27-S27.
Poster
  • 2009. Trace elements in hemochromatosis.
  • 2007. Iron status in blood donors.
  • 2003. Improvement of haemoglobin concentration and iron status in children with chronic adeno-tonsillar infection after surgical treatment.
  • 2001. Inhibited hemoglobin synthesis and increased serum ferritin during hyperoxic saturation diving and after hyperbaric oxygen treatment.
  • 2001. Antioxidant status in patients with Crohn disease before and after oral iron therapy.
  • 2000. Trace element reference values in serum determined by inductively coupled plasma atomic emission spectrometry.
  • 2000. Tetradecylthioacetic acid and tetradecylselenoacetic acid inhibit lipid peroxidation and interact with superoxide radical.
Vitenskapelig oversiktsartikkel/review
  • 2015. The liver in haemochromatosis. 219-224.
  • 2011. Proteomics of human cerebrospinal fluid: Discovery and verification of disease biomarker candidates in neurodegenerative diseases using quantitative proteomics. 371-388.
  • 2009. Hemokromatose - fra underdiagnostiseert kuriositet til folkesykdom. 863-866.
  • 2007. Evaluation of methods for trace-element determination with emphasis on their usability in the clinical routine laboratory. 353-366.
  • 2006. Proteomic-based biomarker discovery with emphasis on cerebrospinal fluid and multiple sclerosis. 147-158.
Fagartikkel
  • 2009. Jernstatus hos blodgivere i Norge : sammenligning av jernstatus hos nye blodgivere registrert i 1993-1997 og i 2005-2006. Bioingeniøren. 6-11.

Se fullstendig oversikt over publikasjoner i CRIStin.